An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer.

A number of indole-3-glyoxylamides have previously been reported as tubulin polymerization inhibitors, although none has yet been successfully developed clinically. We report here a new series of related compounds, modified according to a strategy of reducing aromatic ring count and introducing a greater degree of saturation, which retain potent tubulin polymerization activity but with a distinct SAR from previously documented libraries. A subset of active compounds from the reported series is shown to interact with tubulin at the colchicine binding site, disrupt the cellular microtubule network, and exert a cytotoxic effect against multiple cancer cell lines. Two compounds demonstrated significant tumor growth inhibition in a mouse xenograft model of head and neck cancer, a type of the disease which often proves resistant to chemotherapy, supporting further development of the current series as potential new therapeutics.

• Publication year

  2015

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2015-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.jmedchem.5b01312PMID 26580420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Screening-based translation of public research encounters painful problems.

  2015cited by this paper
• Evaluation of spheroid head and neck squamous cell carcinoma cell models in comparison to monolayer cultures.

  2015cited by this paper
• The Quest for a Simple Bioactive Analog of Paclitaxel as a Potential Anticancer Agent

  2014cited by this paper
• Ixabepilone-induced mitochondria and sensory axon loss in breast cancer patients

  2014cited by this paper
• Recent developments in tubulin polymerization inhibitors: An overview.

  2014cited by this paper
• Tubulin inhibitors: a patent review

  2014cited by this paper
• Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles

  2014cited by this paper
• Polymersome-mediated delivery of combination anticancer therapy to head and neck cancer cells: 2D and 3D in vitro evaluation.

  2014cited by this paper
• Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function.

  2014cited by this paper
• Microtubule Targeting Agents: A Benchmark in Cancer Therapy

  2014cited by this paper
• Eribulin Mesylate in the management of metastatic breast cancer and other solid cancers: a drug review

  2014cited by this paper
• Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities.

  2014cited by this paper
• Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin

  2014cited by this paper
• Interphase microtubules: chief casualties in the war on cancer?

  2014cited by this paper
• Development of other microtubule-stabilizer families: the epothilones and their derivatives

  2014cited by this paper
• Cascade fluorofunctionalisation of 2,3-unsubstituted indoles by means of electrophilic fluorination.

  2013cited by this paper
• Highly regioselective opening of zirconacyclopentadienes by remote coordination: concise synthesis of the furan core of the leupyrrins.

  2013cited by this paper
• Tubulin: an example of targeted chemotherapy.

  2013cited by this paper
• Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy.

  2013cited by this paper
• Three-dimensional cell culture: the missing link in drug discovery.

  2013cited by this paper
• Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy

  2013cited by this paper
• BPR0C305, an orally active microtubule-disrupting anticancer agent

  2013cited by this paper
• A new perspective on old drugs: non-mitotic actions of tubulin-binding drugs play a major role in cancer treatment.

  2013cited by this paper
• Population pharmacokinetic-pharmacodynamic analysis for eribulin mesilate-associated neutropenia.

  2013cited by this paper
• Locating Sweet Spots for Screening Hits and Evaluating Pan-Assay Interference Filters from the Performance Analysis of Two Lead-like Libraries

  2013cited by this paper
• Deciphering the molecular mechanisms of anti-tubulin plant derived drugs

  2013cited by this paper
• Managing ixabepilone adverse events with dose reduction.

  2013cited by this paper
• Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents.

  2012cited by this paper
• Epothilones in development for non--small-cell lung cancer: novel anti-tubulin agents with the potential to overcome taxane resistance.

  2012cited by this paper
• Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancer.

  2012cited by this paper
• The Role of Antiangiogenic Agents in the Treatment of Head and Neck Cancer

  2012cited by this paper
• Tubulins as therapeutic targets in cancer: from bench to bedside.

  2012cited by this paper
• Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies.

  2012cited by this paper
• An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site

  2012cited by this paper
• The proliferation rate paradox in antimitotic chemotherapy

  2012cited by this paper
• Eribulin: A Novel Cytotoxic Chemotherapy Agent

  2012cited by this paper
• Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice.

  2011cited by this paper
• Discovery of 6-substituted indole-3-glyoxylamides as lead antiprion agents with enhanced cell line activity, improved microsomal stability and low toxicity.

  2011cited by this paper
• Emerging therapies in the treatment of locally advanced squamous cell cancers of head and neck.

  2011cited by this paper
• Matched molecular pairs as a medicinal chemistry tool.

  2011cited by this paper
• Vinflunine as second-line treatment in platin-resistant metastatic urothelial carcinoma: a review

  2011cited by this paper
• Eribulin mesylate for the treatment of late-stage breast cancer

  2011cited by this paper
• Drugs that target dynamic microtubules: A new molecular perspective

  2011cited by this paper
• BPR0C261 is a novel orally active antitumor agent with antimitotic and anti‐angiogenic activities

  2011cited by this paper
• Elevated BCRP/ABCG2 Expression Confers Acquired Resistance to Gefitinib in Wild-Type EGFR-Expressing Cells

  2011cited by this paper
• Peripheral neuropathy with microtubule-targeting agents: occurrence and management approach.

  2011cited by this paper
• Structure–Activity Relationship Refinement and Further Assessment of Indole‐3‐glyoxylamides as a Lead Series against Prion Disease

  2011cited by this paper
• The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types.

  2011cited by this paper
• Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry.

  2011cited by this paper
• Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma

  2011cited by this paper
• N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy.

  2011cited by this paper
• Antiproliferative effects of N-heterocyclic indolyl glyoxylamide derivatives on human lung cancer cells.

  2011cited by this paper
• New advances in targeted therapies for squamous cell carcinoma of the head and neck

  2011cited by this paper
• Current status of experimental therapeutics for head and neck cancer

  2011cited by this paper
• Microtubules and resistance to tubulin-binding agents

  2010cited by this paper
• Dose-finding and pharmacokinetic study of orally administered indibulin (D-24851) to patients with advanced solid tumors

  2010cited by this paper
• Multicellular tumor spheroids: an underestimated tool is catching up again.

  2010cited by this paper
• Computationally Efficient Algorithm to Identify Matched Molecular Pairs (MMPs) in Large Data Sets

  2010cited by this paper
• Microtubules and resistance to tubulin-binding agents

  2010cited by this paper
• Lead Optimization Using Matched Molecular Pairs: Inclusion of Contextual Information for Enhanced Prediction of hERG Inhibition, Solubility, and Lipophilicity

  2010cited by this paper
• WizePairZ: a novel algorithm to identify, encode, and exploit matched molecular pairs with unspecified cores in medicinal chemistry

  2010cited by this paper
• Microtubule-binding agents: a dynamic field of cancer therapeutics

  2010cited by this paper
• Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.

  2010cited by this paper
• Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.

  2009cited by this paper
• Indibulin, a novel microtubule inhibitor, discriminates between mature neuronal and nonneuronal tubulin.

  2009cited by this paper
• PREDICTING AQUEOUS SOLUBILITY FROM STRUCTURE

  2009cited by this paper
• Microtubule dynamics as a target in oncology.

  2009cited by this paper
• Escape from flatland: increasing saturation as an approach to improving clinical success.

  2009cited by this paper
• ADMET rules of thumb II: A comparison of the effects of common substituents on a range of ADMET parameters.

  2009cited by this paper
• Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma

  2009cited by this paper
• Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system.

  2009cited by this paper
• The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design?

  2009cited by this paper
• beta-Tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: a companion analysis of the TAX 324 trial.

  2009cited by this paper
• Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity.

  2008cited by this paper
• Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine.

  2008cited by this paper
• N-cyclopropylation of indoles and cyclic amides with copper(II) reagent.

  2008cited by this paper
• 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU)-promoted efficient and versatile aza-Michael addition

  2007cited by this paper
• Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors

  2007cited by this paper
• Research Article: In vivo Evaluation of Indolyl Glyoxamides in the Phenotypic Sea Urchin Embryo Assay

  2007cited by this paper
• Development of a practical synthesis of STA-5312, a novel indolizine oxalylamide microtubule inhibitor

  2007cited by this paper
• A Convenient Aminolysis of Esters Catalyzed by 1,5,7‐Triazabicyclo[4.4.0]dec‐5‐ene (TBD) under Solvent‐Free Conditions.

  2007cited by this paper
• Computational approaches to determine drug solubility.

  2007cited by this paper
• Palliative Chemotherapie von Kopf-Hals-Tumoren: Aktueller Stand und neue Entwicklungen

  2006cited by this paper
• Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure.

  2006cited by this paper
• Spindle checkpoint function and cellular sensitivity to antimitotic drugs

  2006cited by this paper
• A phase 1, dose-escalation trial of STA-5312, a microtubule inhibitor with a novel binding site, in advanced or metastatic solid malignancies.

  2006cited by this paper
• [Palliative chemotherapy of head and neck cancer: present status and future development].

  2006cited by this paper
• Virtual Computational Chemistry Laboratory – Design and Description

  2005cited by this paper
• EXPRESSION, LOCALIZATION, AND FUNCTIONAL CHARACTERISTICS OF BREAST CANCER RESISTANCE PROTEIN IN CACO-2 CELLS

  2005cited by this paper
• Predicting aqueous solubility from structure.

  2005cited by this paper
• Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study

  2005cited by this paper
• Analysis of the horseradish peroxidase/indole-3-acetic acid combination in a three-dimensional tumor model

  2004cited by this paper
• Synthesis and biological evaluation of N-heterocyclic indolyl glyoxylamides as orally active anticancer agents.

  2003cited by this paper
• Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas.

  2002cited by this paper
• An effective procedure for the acylation of azaindoles at C-3.

  2002cited by this paper
• Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices

  2001cited by this paper
• Internet Software for the Calculation of the Lipophilicity and Aqueous Solubility of Chemical Compounds

  2001cited by this paper
• D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity.

  2001cited by this paper
• A novel Cu-assisted cycloisomerization of alkynyl imines: efficient synthesis of pyrroles and pyrrole-containing heterocycles.

  2001cited by this paper
• Evidence for Different ABC-Transporters in Caco-2 Cells Modulating Drug Uptake

  1999cited by this paper

• Scope of Nitrostyrenes in Chemistry and Biology and the Advancement of Their Reactions

  2026cites this paper
• Exploring Indole‐1,3,4‐Thiadiazole Schiff Base Derivatives as Anticancer Agents: Design, Synthesis, In Vitro and In Silico Evaluation

  2025cites this paper
• IMPACT OF SUBSTITUENTS IN INDOLOBENZAZOCIN-8-ONE DERIVATIVES ON ANTICANCER ACTIVITY: INSIGHTS FROM MOLECULAR DOCKING AND ADMET PREDICTIONS

  2025cites this paper
• Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry

  2023cites this paper
• Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors.

  2023cites this paper
• Identification of Novel β-Tubulin Inhibitors Using a Combined In Silico/In Vitro Approach

  2023cites this paper
• Indole-3-Acetamido-Polyamines as Antimicrobial Agents and Antibiotic Adjuvants

  2023cites this paper
• Synthesis and in vitro biological evaluation of (iso)quinoline-1,2,3-triazole derivatives as anticancer agents

  2022cites this paper
• Indole derivatives (2010-2020) as versatile tubulin inhibitors: synthesis and structure-activity relationships.

  2021cites this paper
• Indole derivatives as tubulin polymerization inhibitors for the development of promising anticancer agents.

  2021cites this paper
• A periodic review of chemical and pharmacological profiles of Tubiechong as insect Chinese medicine

  2021cites this paper
• Corticosteroid delivery using oral mucosa equivalents for the treatment of inflammatory mucosal diseases

  2021cites this paper
• Current scenario of indole derivatives with potential anti-drug-resistant cancer activity.

  2020cites this paper
• Design, Synthesis and in vitro Anti-Cancer evaluation of Novel Derivatives of 2-(2-Methyl-1,5-diaryl-1H-pyrrol-3-yl)-2-oxo-N-(pyridin-3-yl)acetamide.

  2020cites this paper
• Discovery of a novel selective water-soluble SMAD3 inhibitor as an antitumor agent.

  2020cites this paper
• Indole-3-Glyoxylamide- An Important Scaffold for Anticancer Activity

  2020cites this paper
• Indole alkaloids, synthetic dimers and hybrids with potential in vivo anticancer activity.

  2020cites this paper
• Synthesis and biological evaluation of indolylglyoxylamide bisphosphonates, antimitotic microtubule-targeting derivatives of indibulin with improved aqueous solubility.

  2020cites this paper
• Bicyclic 5,6-membered With One Heteroatom N

  2020cites this paper
• Design, synthesis, and evaluation of new 2-oxoquinoline arylaminothiazole derivatives as potential anticancer agents.

  2020cites this paper
• In vitro anticancer active cis-Pt(II)-diiodido complexes containing 4-azaindoles

  2019cites this paper
• A class of novel tubulin polymerization inhibitors exert effective anti-tumor activity via mitotic catastrophe.

  2019cites this paper
• Developments in Cp*Co III ‐Catalyzed C−H Bond Functionalizations

  2019cites this paper
• Design, Synthesis and Anticancer Evaluation of Novel Series of Indibulin Analogues.

  2019cites this paper
• Indole: A privileged scaffold for the design of anti-cancer agents.

  2019cites this paper
• CuI incorporated cobalt ferrite nanoparticles as a magnetically separable catalyst for oxidative amidation reaction.

  2019cites this paper
• Direct construction of carbazoles from 2-methyl-indole-3-carbaldehydes and enals

  2019cites this paper
• Design, synthesis and biological evaluation of novel indole-based oxalamide and aminoacetamide derivatives as tubulin polymerization inhibitors.

  2019cites this paper
• Synthesis and anti-breast cancer activity of novel indibulin related diarylpyrrole derivatives

  2019cites this paper
• 2-[2-Methyl-5-phenyl-1-(3,4,5-trimethoxyphenyl)-1H-pyrrol-3-yl]-2-oxo-N-(pyridin-4-yl) acetamide

  2018cites this paper
• Design, synthesis and cytotoxicity evaluation of indibulin analogs

  2018cites this paper
• Novel nicotinoyl pyrazoline derivates bearing N-methyl indole moiety as antitumor agents: Design, synthesis and evaluation.

  2018cites this paper
• Design and synthesis of (aza)indolyl maleimide-based covalent inhibitors of glycogen synthase kinase 3β.

  2018cites this paper
• Carbene-Catalyzed Construction of Carbazoles from Enals and 2-Methyl-3-oxoacetate Indoles.

  2018cites this paper
• The IL‐1/IL‐1R axis induces greater fibroblast‐derived chemokine release in human papillomavirus‐negative compared to positive oropharyngeal cancer

  2018cites this paper
• molbank Communication 2-[ 2-Methyl-5-phenyl-1-( 3 , 4 , 5-trimethoxyphenyl )-1 H-pyrrol-3-yl ]-2-oxoN-( pyridin-4-yl ) acetamide

  2018cites this paper
• Indibulin dampens microtubule dynamics and produces synergistic antiproliferative effect with vinblastine in MCF-7 cells: Implications in cancer chemotherapy

  2018cites this paper
• Learning Medicinal Chemistry Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) Rules from Cross-Company Matched Molecular Pairs Analysis (MMPA).

  2017cites this paper
• Synthesis, antitumor activity and CDK1 inhibiton of new thiazole nortopsentin analogues.

  2017cites this paper
• A [4 + 1] Cyclative Capture Access to Indolizines via Cobalt(III)-Catalyzed Csp(2)-H Bond Functionalization.

  2016cites this paper
• Direct reductive coupling of indoles to nitrostyrenes en route to (indol-3-yl)acetamides

  2016cites this paper
• Synthesis and preliminary evaluation of 3-thiocyanato-1H-indoles as potential anticancer agents.

  2016cites this paper
• Novel Natural Product- and Privileged Scaffold-Based Tubulin Inhibitors Targeting the Colchicine Binding Site

  2016cites this paper
• Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth.

  2016cites this paper
• Microwave-assisted heteropolyanion-based ionic liquid promoted sustainable protocol to N-heteroaryl amides via N-directing dual catalyzed oxidative amidation of aldehydes

  2016cites this paper
• Synthesis and Determination of Physicochemical Properties of New 3-(4-Arylpiperazin-1-yl)-2-hydroxypropyl 4-Alkoxyethoxybenzoates

  2016cites this paper
• The dicarbonylation of indoles via Friedel–Crafts reaction with dicarbonyl nitrile generated in situ and retro-cyanohydrination

  2016cites this paper